Triptorelin embonate

Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression

Items (National)
26.5K
NHS Cost
£10.6M
Practices
2,661
Avg per Practice
10

Overview

Triptorelin embonate is prescribed by 2,661 GP practices across England. In the last 12 months, 26,490 items were prescribed at a total cost of £10,633,491 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
NE 2,460 100 25 +146.0% ▲
CV 1,799 73 25 +146.0% ▲
L 1,399 75 19 +87.0% ▲
OX 1,162 36 32 +223.0% ▲
WF 1,083 34 32 +219.0% ▲
WA 1,034 48 22 +115.0% ▲
CH 1,008 35 29 +188.0% ▲
EX 965 33 29 +192.0% ▲
DH 870 30 29 +190.0% ▲
NG 612 28 22 +119.0% ▲
BS 571 22 26 +160.0% ▲
SR 499 22 23 +127.0% ▲
OL 437 24 18 +82.0% ▲
BH 424 14 30 +203.0% ▲
WD 395 15 26 +163.0% ▲
TQ 389 14 28 +178.0% ▲
NN 384 19 20 +102.0% ▲
HP 366 17 22 +115.0% ▲
SO 295 11 27 +168.0% ▲
TA 272 11 25 +147.0% ▲
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.